Wensheng Qiu

机构：Qingdao University, Hunan University, Affiliated Hospital of Qingdao University · ORCID：0000-0002-5063-7830

发表论文 88 篇 · 总被引 2103 次 · h-index 22

代表论文

• Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial (2025 · The Lancet · 被引 128)
• Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 29)
• Cinobufagin loaded Prussian blue-like nanoparticles for chemo/gas therapy of multidrug resistant cancer (2025 · Journal of Nanobiotechnology · 被引 23)
• Gamabufotalin loaded micro-nanocomposites for multimodal therapy of metastatic TNBC by efficiently inducing ICD (2024 · Biomaterials · 被引 22)
• Cepharanthine sensitizes gastric cancer cells to chemotherapy by targeting TRIB3-FOXO3-FOXM1 axis to inhibit autophagy (2024 · Phytomedicine · 被引 21)
• UBC9 stabilizes PFKFB3 to promote aerobic glycolysis and proliferation of glioblastoma cells (2023 · The International Journal of Biochemistry & Cell Biology · 被引 16)